{
    "SPADE_N_05861": {
        "Clinical Information": [],
        "Patent Information": [
            {
                "Patent No": "US 2022/0125873 A1",
                "Patent Link": "http://www.lens.org/lens/patent/US_2022_0125873_A1",
                "Patent Type": "Patent Application",
                "Publication Date": "2022-4-28",
                "Family Info": "WO2020/118427A1##CA3123101A1##BR112021011276A2##EP3897128A1##JP2022523896A##US2022/0125873A1##EP3897128A4",
                "Patent Title": "Antimicrobial Peptides",
                "Abstract": "Antimicrobial peptides (AMPs), small compounds that often exhibitbroad spectrum antimicrobial activity, are garnering interest as potential therapeutics against antibiotic-resistant bacterial pathogens. Development of new AMPs is arduous due to the practical limitations of classical protein-based discovery approaches. A high throughput bioinformatics approach is described which is able to confirm identification of known AMPs from the North American bullfrog ( Rana ( Lithobates ) catesbeiana ) genome, and a bioinformatics approach is used to develop new AMPs. The described AMPs exhibit antimicrobial activity against Mycobacterium smegmatis via microtitre broth dilution assays, indicating broader efficacy."
            }
        ],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_05861",
            "Peptide Name": "Catesbeianin-1 (Ranidae, Anura, Amphibia, Animals)",
            "Source": "Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "MMRVMRRKTKVIWEKKDFIGLYSID",
            "Sequence Length": 25,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/C5IAX4"
            ],
            "Protein Existence": "Transcript level",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "[Ref.28258530] Gram-positive bacteria :Staphylococcus aureus ATCC 25923 (MIC=3.1 μg/ml;MBC=6.3 μg/ml), B. subtilis ATCC6633 (MIC=25 μg/ml;MBC=50 μg/ml), Streptococcus suis CVCC606 (MIC=3.1 μg/ml;MBC=12.5 μg/ml), Listeria monocytogenes ATCC19115 (MIC=12.5 μg/ml;MBC=25 μg/ml);Gram-negative bacteria :Escherichia coli ATCC 25922 (MIC=3.1 μg/ml;MBC=12.5 μg/ml), Pseudomonas aeruginosa ATCC227853 (MIC=12.5 μg/ml;MBC=25 μg/ml), Salmonella spp. CVCC 3377 (MIC=6.3 μg/ml;MBC=25 μg/ml), Klebsiella pneumoniae H507 (MIC=25 μg/ml;MBC=100 μg/ml)",
            "Hemolytic Activity": "[Ref.28258530] 0% hemolysis at 0 μg/ml , hemolysis 3% at 25 μg/ml , 7% hemolysis at 50 μg/ml , 8% hemolysis at 100 μg/ml , 35% hemolysis at 200 μg/ml , 50% hemolysis at 300 μg/ml , 85% hemolysis at 400 μg/ml , 95% hemolysis at 500 μg/ml against human red blood cells",
            "Cytotoxicity": "[Ref.28258530] The cell viability of HEK293T cells is 102%, 103%, 103%, 100%, 98% and 85% at peptide concentrations of 0, 20, 40, 60, 80 and 100 μg/ml.The cell viability of HL-7200 cells is 107%, 106%, 99%, 95% and 88% at peptide concentrations of 0,",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Catesbeianin-1 is an amphi pathic a-helix and that the helical wheel is divided into two parts, namely, a hydrophobic face and a hydro philic face.",
            "Formula": "C142H235N39O35S3",
            "Mass": 3144.82,
            "PI": 10.16,
            "Net Charge": 4,
            "Hydrophobicity": -0.38,
            "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour",
            "Function": "Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria",
            "Literature": [
                {
                    "Title": "Catesbeianin-1, a novel antimicrobial peptide isolatedfrom the skin of Lithobates catesbeianus (American bullfrog)",
                    "Pubmed ID": "28258530",
                    "Reference": "Biotechnol Lett. 2017 Jun;39(6)897-903. doi 10.1007/s10529-017-2312-7.",
                    "Author": "Huihui Xu . Yang Zhang . Xin Feng . Kunyuan Tie . Yuan Cao . Wenyu Han",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=28258530"
                }
            ],
            "Frequent Amino Acids": "KIM",
            "Absent Amino Acids": "ACHNOPQU",
            "Basic Residues": 7,
            "Acidic Residues": 3,
            "Hydrophobic Residues": 12,
            "Polar Residues": 12,
            "Positive Residues": 7,
            "Negative Residues": 3,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_13657",
                    "Similarity": 1.0,
                    "Sequence": "MFTMKKSEKERRERGKRMMRVMRRKTKVIWEKKDFIGLYSID"
                },
                {
                    "SPADE_ID": "SPADE_UN_13658",
                    "Similarity": 1.0,
                    "Sequence": "MRKRMTMRRMMKKKKSEKERRERGKRMMRVMRRKTKVIWEKKDFIGLYSID"
                }
            ]
        }
    }
}